Aurobindo Pharma’s arm recalls 59.5 thousand vials of antipsychotic injection from US

13 Dec 2019 Evaluate

Aurobindo Pharma’s arm -- AuroMedics Pharma LLC has initiated recall of 59.5 thousand vials of antipsychotic Fluphenazine Decanoate injection USP 125mg/5mL, (5 mL multiple dose vial) from the US market. The recalling of 59,500 vials of the injection is on account of ‘Discoloration; hazy solution found in one vial instead of a clear solution’.

The product was distributed to major wholesalers/distributors who may have further distributed the product throughout the US. The voluntary ongoing recall is a class II recall.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1210.20 -15.95 (-1.30%)
04-Feb-2026 14:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1705.45
Dr. Reddys Lab 1243.60
Cipla 1329.50
Zydus Lifesciences 903.05
Lupin 2198.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×